


SARS-CoV-2 Spike Protein S1 Receptor-Binding Domain (S1RBD)
SIZE
0.1 mg
INTRODUCTION
Since December 2019, outbreak of SARS-CoV-2 infection has become a major epidemic threat in China and brought back the attention of pathogenic coronavirus to the spotlight. Spike protein is an envelope-anchored protein that mediates the recognition and binding of SARS-CoV-2 to host cells. S1 can be further cleaved by the host protease into two subunits called S1 and S2, wherein the S1 polypeptide contain a receptor binding domain (RBD) crucial for the specific recognition and interaction with human receptor ACE2, which is the first and the most essential step for the virus infection.
Expressed in E.coli with total 194 AA. Mw: 21.8 KDa (calculated).
Recombinant antigen for research use or manufacturing only.
SIZE
0.1 mg
INTRODUCTION
Since December 2019, outbreak of SARS-CoV-2 infection has become a major epidemic threat in China and brought back the attention of pathogenic coronavirus to the spotlight. Spike protein is an envelope-anchored protein that mediates the recognition and binding of SARS-CoV-2 to host cells. S1 can be further cleaved by the host protease into two subunits called S1 and S2, wherein the S1 polypeptide contain a receptor binding domain (RBD) crucial for the specific recognition and interaction with human receptor ACE2, which is the first and the most essential step for the virus infection.
Expressed in E.coli with total 194 AA. Mw: 21.8 KDa (calculated).
Recombinant antigen for research use or manufacturing only.